Comment on CMS-2026-1255-0001
HTD HealthSupportAdvocacy
Summary: HTD Health, an interoperability practice, supports the proposed rule but recommends specific technical refinements, such as designating a deterministic benefit-type routing signal for drug prior authorization and phasing the implementation timeline to ensure quality. They also advocate for immediate payer API technology certification and making electronic event notifications nationally available by moving away from a request-driven model.
We respectfully submit this comment to Administrator Oz, Deputy Administrator Gleason, and the rest of the CMS crew. 🫡